Podcasts about laguna hills

 Today, we're heading to Laguna Hills in California to chat with the founder of ELAJ, Suhein Beck. Suhein is affectionately known as the culture cultivator. She's a dynamic speaker, author, and entrepreneur, a proud Circassian with roots tracing back to the legendary Amazon women. Heck, we may have even traced her lineage back to Leonardo da Vinci. Currently, Suhein has launched an international speaking tour and campaign that draws on her rich heritage to challenge mainstream narratives and ignite transformative leadership to develop their own higher standards and adopt a personal code of honor.  Visit the C4C website to gain full access to the transcript, show notes, and guest links. Coaching 4 Companies

In this episode John A. Hovanesian, MD, FACS, and Jim Mazzo are live from SightLine at the ASCRS meeting with guests Nicole R. Fram, MD, Kerry D. Solomon, MD, Vance Thompson, MD, and Steve Speares. Welcome to the Eyeluminaries podcast 00:02 Review of episode 32 00:55 Intro of Nicole Fram, MD 01:16 Tell us why the MAHRVELS team is likely to be the leading fundraisers and why you picked your character for the team to portray (The Scarlet Witch)? 02:24 Meeting about complications from cataract surgery, what do you think is the next big phase on how we're going to handle complications with technology? 04:05 Psychology of managing patients/conveying care 05:42 What advice do you give to people who are starting their career? 06:50 Intro of Kerry Solomon, MD 09:30 What do we often get wrong with cataract surgery and what do we often get right? 10:25 How do you stay an entrepreneur and a leading physician? 11:55 What is Operation Sight? How did you create it? 14:19 Where will keratorefractive surgery and lens-based surgery be in 5 or 10 years? 18:30 Intro of Vance Thompson, MD 21:24 What's it like to be ASCRS president? 21:59 What is BRiCS and why is it important? 23:54 You've created a culture; can you talk about that culture you've created at your institute? 29:30 Tell us about your winery! 33:28 Intro of Steve Speares 36:45 ASCRS just wrapped up. Your idea of creating a SightLine with a business approach, what did you do and what was the idea? 38:00 As you look back and you look ahead, what changes do you hope to make? What do you hope your legacy will be at ACSRS? 40:57 Can you expand more on how Washington, DC and Trump administration will impact your society/group? 44:19 Richard Lindstrom in ASCRS hall of fame, tell us your own perspective and a good story 46:29 Preview of episode 34 52:09 Give us your feedback 52:40 Thanks for listening 52:56 Nicole Fram, MD, is an adjunct assistant professor at the John A. Moran Eye Institute at the University of Utah. She is also the secretary for ASCRS, is a member of the Cataract Clinical Committee, and leads the Ophthalmology Quicksand Chronicles podcast with co-host Elizabeth Yeu, MD. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Kerry Solomon, MD, is internationally renowned for LASIK and refractive cataract surgery. He is the co-founder of Operation Sight. He is the former chairman of the ASCRS FDA Committee. Steve Speares, MD, is the executive director at ASCRS. Vance Thompson, MD, is the founder of Vance Thompson Vision and director of refractive surgery in Sioux Falls, SD. He serves as a professor of ophthalmology at the Sanford School of Medicine at the University of South Dakota. Thompson is the immediate past president of ASCRS. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Fram, Speares, Solomon, and Thompson at the time of publication.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10 What do you think about the leadership? 23:44 Let's talk about sustainability. Tell us about the medical device industry's collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59 Let's talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53 Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20 Preview of episode 33 39:27 Give us your feedback 40:23 Team Mah-rvel: the Party for a Purpose 40:41 Thanks 40:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA). Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.

Sylvia Messner, from Laguna Hills, California, USAAre you or someone you know interested in interning at The Mother Church? Go to christianscience.com/internships.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA. Welcome to the Eyeluminaries podcast :02 Review of episode 30 3:23 Intro of Paul Singh, MD 3:40 What are the future trends in glaucoma you're most excited about? 5:10  What challenges do you see in running your practice that didn't exist in your dad's day? 8:36 You've got a great medical office, a very busy consulting and research practice, you play in a band and you have a young family. What advice would you give others in keeping it all in balance? 12:09 Besides your dad and the two of us, who do you look up to in eye care? 14:45 Singh sings a Funkadesi song 18:16 Intro of Candy Simerson 20:36 When you come into a new practice to consult, what are the most common areas you see where improvement can be made? 21:41 What about the finances? What areas in finances do you see where improvement can be made? 24:27 In your many years in ophthalmology, what are the biggest challenges you've experienced? 26:10 What type of practice should consider a sale to private equity? What type of practice should not? 29:34 What advice would you give a company representative who wants to win business from a big ophthalmology practice? 32:29 Intro of the Goldbergs 36:25 Jeff Goldberg, MD, PhD 36:50 Roger Goldberg, MD, MBA 37:21 Jeff, why glaucoma instead of retina? 38:43 Roger, why retina instead of glaucoma? 39:37 Mazzo discusses neuroprotection in retina and glaucoma. 41:14 What is entrepreneurship like today? What's your advice? What is challenging and what is positive? 43:10 Mazzo discusses being realistic about innovations. 48:30 What is private practice like today? 49:31 How do cornea specialists better understand glaucoma specialists? 53:05 How do cornea specialists better understand retina specialists? 54:13 Tell us about emmecell. 55:50 Preview of episode 32 59:19 Give us your feedback 1:00:18 Thanks 1:00:30 Jeffrey Goldberg, MD, PhD, is professor and chair of ophthalmology at the Byers Eye Institute at Stanford University and a member of the National Academy of Medicine. Roger Goldberg, MD, MBA, board certified by the American Board of Ophthalmology and is an active member of the American Society of Retinal Specialists, the Retina Society and the American Academy of Ophthalmology. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Candy Simerson is the senior vice president of practice operations at Vision Integrated Partners. I. Paul Singh, MD, is the president of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He is a founding member of the band, Funkadesi, a mix of Indo-Afro-Caribbean style music. The band tours the world spreading the message “one family, many children.” We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for the Goldbergs, Simerson and Singh at the time of publication.

Sylvia Messner, from Laguna Hills, California, USASubmit to the Christian Science Daily Lift. We'd love to hear your inspiration.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Steven Dell, MD, about his career and the creation of markets in the field of ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 29 1:28  Bausch + Lomb acquires Elios Vision 2:07  ImprimisRx awarded $34.9 million in trademark infringement suit against OSRX 5:00  Study of atropine-based myopia treatment fails to meet primary efficacy endpoint 7:31  Intro of Steven Dell, MD 11:20 You have created markets with new technologies and companies. Can that continue in today's market? 13:28 Dell discusses presbyopia market development. 14:11 You created a questionnaire that you used in your practice, which has become known as the Dell Questionnaire. What do we need to do better in treating our cataract patients? 16:20 What technologies are going to be the most important in the future? 20:24 What has changed in your office environment, i.e., the role of ODs, admin, staff? 22:00 Dell discusses Lindstrom's Integrated Eye Care Delivery Model. 23:08 What advice would you give a younger Steven Dell? 27:16 Neurotech Pharmaceuticals announced that chief commercial officer Scott Hunter died on Dec. 3. 33:06 Give us your feedback 34:43 Thanks 34:51 Steven J. Dell, MD, is a board-certified ophthalmologist in Austin and the Medical Director of Dell Laser Consultants. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Dell at the time of publication.

In this special crossover episode, Eyeluminaries hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are joined live by Susan MacDonald, MD, and Cathleen McCabe, MD, at Eyecelerator 2024 in Chicago, IL. Intro :07 Welcome to the Eyeluminaries podcast 3:14 In this episode 5:02 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 5:11 What started you on this journey to do humanitarian work? 5:30 MacDonald discusses the role of parents in defining of happiness. 10:56 Hovanesian discusses the background of his humanitarian work in Armenia. 11:36 What about the funding of these humanitarian projects? 12:50 What are your stories from doing humanitarian work? 14:11 What advice to do you have for physicians who want to get involved in humanitarian work? 18:55 Hovanesian discusses the commonalities in MacDonald and McCabe's humanitarian missions. 22:23 McCabe discusses the commonalities in Hovanesian and MacDonald's humanitarian missions. 22:50 MacDonald discusses how her humanitarian work began. 23:28 Thank you. 27:05 MacDonald talks about the ophthalmic industry and their contribution to humanitarian work. 27:51 McCabe discusses ways physicians can get involved in humanitarian work without having to travel overseas. 28:42 Visit ACE Global, Cybersight or Operation Sight to get involved. 28:54 Mend the Gap podcast 30:49 Preview of episode 30 32:17 Give us your feedback 32:44 Thanks 33:17 Thoughts 33:27 Visit the ASCRS Foundation to get involved in Operation Sight. 34:20 Thank you for listening! 35:17 Don't forget to like and subscribe to Mend the Gap and Eyeluminaries! 35:39 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Susan MacDonald, MD, is president of Eye Corps and associate clinical professor at Tufts School of Medicine. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on X (formerly Twitter) @Healio_OSN. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. MacDonald and McCabe report no relevant financial disclosures.

In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, are live from Eyecelerator with Mend the Gap hosts Susan MacDonald, MD, and Cathleen McCabe, MD, discussing their humanitarian work. Welcome to the Eyeluminaries podcast :02 In this episode :31 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 1:00 What started you on this journey to do humanitarian work? 2:18 MacDonald discusses the role of parents in defining of happiness. 7:47 Hovanesian discusses the background of his humanitarian work in Armenia. 8:24 What about the funding of these humanitarian projects? 9:38 What are your stories from doing humanitarian work? 10:59 What advice to do you have for physicians who want to get involved in humanitarian work? 15:43 Hovanesian discusses the commonalities in MacDonald and McCabe's humanitarian missions. 19:11 McCabe discusses the commonalities in Hovanesian and MacDonald's humanitarian missions. 19:38 MacDonald discusses how her humanitarian work began. 20:16 Thank you. 23:49 MacDonald talks about the ophthalmic industry and their contribution to humanitarian work. 24:39 McCabe discusses ways physicians can get involved in humanitarian work without having to travel overseas. 25:30 Visit ACE Global, Cybersight or Operation Sight to get involved. 25:38 Mend the Gap podcast 27:37 Preview of episode 30 29:05 Give us your feedback 29:25 Thanks 30:05 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Susan MacDonald, MD, is president of Eye Corps and associate clinical professor at Tufts School of Medicine. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. MacDonald and McCabe report no relevant financial disclosures.

Sylvia Messner, from Laguna Hills, California, USA

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 26 :58 FDA grants fast track designation to brepocitinib for noninfectious uveitis 1:42  I. Howard Fine, MD, esteemed ophthalmologist, dies 3:54 First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia 5:48 LENZ Therapeutics submits NDA for drops to treat presbyopia 7:57 Intro of Tom Mitro 10:40 Tell us about your journey in ophthalmology 12:38 Tell us about the new dry eye drug from Signal 12. 15:53 How much sensation is on the forehead if the drug is well tolerated? 24:13 What are your thoughts on the current ophthalmology market? 26:01 Tell us a funny story about Jim Mazzo and about John Hovanesian. 28:51 Preview of episode 29 33:25 Give us your feedback 34:34 Thanks 34:50 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Tom Mitro is the president and chief operating officer for Aerie Pharmaceuticals. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Mitro at the time of publication.

In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care. Welcome to the Eyeluminaries podcast :10 About Steven Schwartz, MD 2:32 The interview 3:16 Discussion of current innovation in cataract surgery including use of AI, imaging and robotics 4:05 Discussion on Schwartz's involvement in Neurotech MacTel cell-based treatment 6:32 Advances and disappointments in retinal disease treatments? 10:32 How do companies come back from disappointing trial results? 11:07 Why do retina discoveries take so long to develop? 14:31 New dry AMD treatments in development? 15:58  Drug delivery technologies and will retina specialists use them? What do you predict we'll be doing differently in medicine 2 years from now and why? 22:00 What's the difference between a retina and cornea specialist? 23:52 Introduction of Sean Ianchulev, MD, MPH 25:38 The interview 26:29 Impact on Google Glass 30:27 What innovations are you proud of and what projects are you excited about? 35:31 What advice do you have for new entrepreneurs? 42:16 How do you balance your work life and your home life? 45:25 Legends in the field of ophthalmology 47:39 Give feedback at eyeluminaries@healio.com 49:36 Thanks for listening 49:57 Sean Ianchulev, MD, MPH, is a Harvard-trained physician-scientist, a professor of ophthalmology and the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss and AMO. Steven Schwartz, MD, is the Ahmanson professor in ophthalmology and the chief of the retina division at the UCLA Jules Stein Eye Institute and the director of the Diabetic Eye Disease and Retinal Vascular Center. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. You can reach Dr. Schwartz via email at schwartzpatients@jsei.ucla.edu. You can find Dr. Ianchulev on LinkedIn.  Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Schwartz is the co-founder of Horizon Surgical; member on the National Eye Institute Audacious Initiative Scientific executive committee and reports receiving grants from Neurotech, Optos/Nikon, the California Institute of Regenerative Medicine; and investigator fees from Neurotech and Optos/Nikon and the California Institute of Regenerative Medicine.

Cheryl Ranson, from Laguna Hills, California, USAHear more from Cheryl on this week's episode of Sentinel Watch.

Welcome to FractureLine: the official weekly news feed from the Chest Wall Injury Society, where we will listen to all the bottom-line CWIS updates, shout-outs, fun facts, and weekly banter! This week's episode welcomes Drs. Rodney Gabriel, MD, MAS (UCSD) and Igor Filipovski, MD (CCryo Center Copenhagen, Copenhagen, DK)! Drs. Filipovski and Gabriel are members of the International Society of Ultrasound Guided Cyroneurolysis (ISUGC). We got to talk with them about their new article published in the Current Pain & Headache Reports: "A Narrative Review of Ultrasound-Guided and Landmark-based Percutaneous Cryoneurolysis for the Management of Acute and Chronic Pain." We were also joined by SarahAnn, Dr. White, Dr. Bauman, and Dr. Kryskow. Finally, we get some weekly updates and a reminder that CWIS International is right around the corner! It's a scorcher outside so come listen to some cryo facts and chill out with us! **To end this episode (post-credits), we will hear the reflections from CWIS Member Dr. Ford Powell, MD, (Laguna Hills, CA), from CWISummit 2024**

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo chat with Cathleen McCabe, MD, about the ASCRS Foundation and role models in ophthalmology; plus, the latest news in eye care. •    Welcome to the Eyeluminaries podcast :05 •    Review of episode 25 :46 •    Bausch + Lomb acquires Trukera Medical 1:32  •    CMS proposes cutting physician payments for fifth straight year 4:09 •    FDA clears Alcon's Unity cataract system, Unity vitreoretinal cataract system 7:40 •    FDA approves Eylea biosimilar FYB203/Ahzantive 11:07 •    Intro of Cathleen McCabe, MD 13:07 •    American Society of Cataract and Refractive Surgery (ASCRS) has become an important organization to advocate, educate and organize doctors and their practices. As future president of the organization, what vision do you have for the organization? 15:26 •    In reference to your practice, what challenges are you facing and how do you overcome them? 18:59 •    Besides the two of us, who do you admire in ophthalmology? 23:37 •    Tell us about your work, what you do and how you do it. 27:21 •    Preview of episode 27 33:30 •    Thanks 34:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. McCabe reports no relevant financial disclosures.

If you're creating a home gym in Laguna Hills, Las Flores, or Mission Viejo, RX Fitness Equipment (949-770-9900) is now holding a summer savings sale on a wide range of commercial-quality equipment. Go to https://rxfitnessequipment.com for more information. RX Fitness Equipment City: Thousand Oaks Address: 2388 E Thousand Oaks Blvd Website: https://rxfitnessequipment.com Phone: +1-805-497-7000 Email: info@rxfitnessequipment.com

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Octane OTF with Euan Thomson, PhD, Barry Kuppermann, MD, Jeffry Weinhuff, Ehsan Sadri, MD, FACS, and a special announcement from Rich Small. Welcome to the Eyeluminaries podcast :05 Review of episode 24 1:38 Intro of Euan Thomson, PhD 2:10 What kind of companies did you like working for the most? 3:14 Can you comment on why adoption of digital solutions is slow and what we can do about it? 4:15 Geographically speaking, what is the area that is doing the best to incorporate new practices in medicine? 6:04  Can you talk about any real-world evidence of the value of using digital ophthalmic workflows being realized today? 7:51 Intro of Barry Kuppermann, MD, PhD 13:06 Before his passing, you had several years where you worked with one of the most beloved people in ophthalmology, Roger Steinert. What it was like to work with him? Tell us a fun or inspiring story. 15:51 What are the biggest challenges today in resident/fellow education? What advice would you give graduating residents/fellows? 18:05 GHEI has a strong research program. Does it get tougher each year to fund quality research? 20:01 Where do you want to see GHEI in the long-term? 23:55 Intro of Jeffry Weinhuff 26:02 Tell us about your career before entering eye care investing. What is different about our unique specialty within healthcare? 26:38 Tell us about the Visionary Ventures Fund. Is it looking for new physician investors? 30:24 Announcement from Rich Small 34:12 What does Neurotech do? 36:56 Intro of Ehsan Sadri, MD, FACS, FAAO 38:48 Doctors frequently get asked to make investments in start-up companies. How do you decide if an investment is a good one? 42:13 What do you think have been the most innovative companies in eye care during your career? 45:09 Preview of episode 26 49:33 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Barry Kuppermann, MD, PhD, is the Roger F. Steinert professor, chair of the department of ophthalmology and director of the Gavin Herbert Eye Institute at the University of California, Irvine. He also holds a joint appointment with the department of biomedical engineering at UC Irvine. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Ehsan Sadri, MD, FACS, FAAO, is board-certified, fellowship-trained in treating LASIK, cataract and glaucoma surgeries with locations to serve patients in Newport Beach, Santa Ana and Orange. He is also CEO and founder of Visionary Eye Institute and general partner and co-founder of Visionary Ventures Fund (Visionaryvc.com). Rich Small is CEO and member of the board of directors for Neurotech. Euan Thomson, PhD, is the president of ophthalmic devices and head of digital business unit at Carl Zeiss Meditec Inc. Jeffry Weinhuff is the chief investment officer and managing partner of Visionary Ventures Fund, a later-stage venture fund focused on investing in drugs and devices for the eye. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Sadri is the CEO and founder of Visionary Eye Institute and general partner and co-founder of Visionary Ventures Fund. Weinhff is the managing partner of Visionary Ventures Fund. Small is chief executive officer and member of the board of directors for Neurotech. Thomson is the president of ophthalmic devices and head of digital business unit at Carl Zeiss Meditec Inc. Weinhuff is the managing partner of Visionary Ventures Fund.

* Join us in Laguna Hills, California, for our annual conference featuring engaging speakers, workshops on key issues, great food, and fellowship with fellow patriotic Americans - JBS.org * We Discuss The 'Hidden' (In Plain Sight) Dangers Of The Government Controlled "School Choice" Movement! * Louisiana is set to become the first state to mandate the display of the Ten Commandments in public school classrooms under a bill signed into law by Gov. Jeff Landry - AP. * Louisiana Gov. Jeff Landry signed school choice legislation, becoming the 12th state to enact universal school choice. * What is universal School Choice? - School choice allows public education funds to follow students to the schools or services that best fit their needs —whether that's to a public school, private school, charter school, home school or any other learning environment families choose. * Since 1981, the United States government has spent over $2.2B in federal funds on abstinence-only programs. * Success in Classrooms - John Stossel, TheNewAmerican.com Government-run schools keep failing - It shouldn't surprise us. Monopolies rarely serve customers well. * People call them “public schools,” but “government-run” is more accurate. After all, charter schools are available to the public. Privately run supermarkets are open to the public for more hours than “public” schools are.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss leadership in eye care with guest Jack T. Holladay, MD, MSEE, FACS. Brought to you by Johns Hopkins University. •  Welcome to the Eyeluminaries podcast :21 •  Review of episode 23 1:19 •  Blog by John A. Hovanesian, MD, FACS 3:10 •  Merck to acquire EyeBio 4:14 •  FDA approves aflibercept biosimilars Yesafili, Opuviz 6:26 •  Aurion Biotech completes enrollment in phase 1/2 corneal edema cell therapy trial 8:43 •  Intro of Jack Holladay, MD, MSEE 11:10 •  How did you develop a passion for optics? Did you know it was going to be your future? 13:50 •  Holladay's life-threatening situation 16:21 •  Holladay's experience teaching residents 23:50 •  Holladay's optics strategy for improving his golf game 28:33 •  Preview of episode 25 32:25 •  Feedback, questions and guest suggestions at eyeluminaries@healio.com 32:45 Jack T. Holladay, MD, MSEE, FACS, is a clinical professor of ophthalmology at Baylor College of Medicine and retired from clinical ophthalmic practice. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus.

This exciting episode of Rethink Real Estate Ben Brady sits down with Rachael Ashley, a fast-rising star in the Orange County real estate scene from Harcourts Prime Properties - Monarch Beach. Rachael has quickly built a formidable repeat and referral business, and today's discussion focuses on her highly successful marketing campaign for a recent property sale in Laguna Hills. Rachael utilized Harcourts' non-distressed auction process to not only discover the true market value of a very unique property but also to significantly expand her client database. She successfully drew nearly 200 interested groups to the property, many of whom were not actively represented by an agent. Ultimately, 10 of the 25 registered buyers on auction day were ultimately represented by Rachael herself. This is a must-listen episode as Rachael shares the strategies that helped her turn these leads into potential future business, providing valuable insights for any agent looking to enhance their marketing tactics and grow their client base.

Sylvia Messner, from Laguna Hills, California, USA

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo chat with Terry Kim, MD, and Stephen Lane about their careers and transitions at Alcon. Brought to you by Johns Hopkins University. Welcome to the Eyeluminaries podcast :21 Review of episode 22 1:27 Intro of Stephen Lane 2:41 Intro of Terry Kim, MD 6:02 Lane: Why retire? What's next? 7:54 Kim: Why the move to the industry? 10:35 Lane: What does a chief medical officer do? What did you learn from the time you went from practice to CMO, and what were some of the surprises? 13:14 Kim: What do you see as some of the challenges you will be facing? 18:19 Lane: What will you miss the most about being a CMO? 21:03 In your experience, how do you navigate transitions in a company and lead without losing focus? 24:22 Preview of episode 24 30:45 Feedback, questions and guest suggestions at eyeluminaries@healio.com 31:34 Thanks for listening 32:08   John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Terry Kim, MD, is a professor of ophthalmology at Duke University Eye Center. Stephen Lane is a founding partner of Associated Eye Care. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news in eye care and chat with Wiley A. Chambers, MD, about his career in the FDA and his plans for retirement. Brought to you by Johns Hopkins University Welcome to the Eyeluminaries podcast :21 Review of episode 21 :50 Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain 2:49 PulseSight Therapeutics launches with focus on non-viral gene therapies 5:31 FDA clears first investigational new drug application for neuropathic corneal pain 7:59 APX3330 ‘promising' oral treatment option for slowing progression of diabetic retinopathy 10:20 H. Dunbar Hoskins Jr., decorated glaucoma specialist, dies 11:55 Intro of Wiley A. Chambers, MD 13:36 What are you most proud of accomplishing in your 36 years at the FDA? 15:54 What about oral therapies for the eye? 17:30 What do you wish you could change? 18:46 What advice would you give an innovator with a new drug idea? 21:31 What's next for Wiley Chambers? Ocular Advisors, LLC 23:17 What has changed since you left the FDA? 25:11 Second annual drug name awards: The Year of Vs and Ys 27:04 “Needs to buy a vowel” award 28:49 “i before e” award 30:23 “Most likely to be misspelled” award 31:44 “Is there a way to pay for it?” award 33:17 The cutesy award 34:29 “Need an award” award 36:10 Preview of episode 23 38:17 Feedback, questions and guest suggestions at eyeluminaries@healio.com 39:59 Thanks for listening 39:36 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Wiley A. Chambers, MD, is a clinical professor of ophthalmology and adjunct assistant professor of computer medicine at The George Washington University and owner of Ocular Advisors, LLC. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Chambers is the owner of Ocular Advisors, LLC. Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus.

GUEST 1 OVERVIEW: Dustin Olson is a pollster associated with American Pulse Research & Polling. He also hosts the Political Trade Secrets Podcast and works as a political strategist at Olson Strategies & Advertising. You can find him on Twitter at @DustinOlson. GUEST 2 OVERVIEW: Assemblymember Diane Dixon, R-Newport Beach, is a pragmatic businesswoman and former Mayor, who represents the 72nd Assembly District in the California Legislature, which includes Seal Beach, Huntington Beach, Newport Beach, Laguna Beach, Aliso Viejo, Laguna Hills, Laguna Woods and Lake Forest. GUEST 3 OVERVIEW: Mr. Vecchione is a Senior Litigation Counsel for the non-profit New Civil Liberties Alliance representing clients pro-bono against the Administrative State. He was previously President and CEO of the non-profit Cause of Action Institute, also advancing the constitutional order.

Quick episode summary John A. Hovanesian, MD, FACS, and Jim Mazzo sit down with guests Eric D. Donnenfeld, MD, Calvin C. Roberts, MD, Mark L. Baum and Jeannette Bankes to discuss private equity, industry breakthroughs and more. Welcome to the Eyeluminaries podcast :00 Review of episode 20 1:16 Intro of Eric D. Donnenfeld, MD 2:06 Understanding the role of private equity: where does it stand and where is it going? 4:22 Do you see a relief in interest rates and the pace picking up for private equity in the years ahead? 7:19 What are the technologies that you are most excited about? 8:17 What are the things to watch out for? 11:08 Do you have an interesting James Worthy story? 13:34 Intro of Calvin C. Roberts, MD 15:21 Transplanting eyes and Advanced Research Project Agency for Health (ARPA-H) 15:48 How does a chief medical officer work within a company? 18:56 How is what ARPA-H doing different than simply transplanting an eye? 20:42 Intro of Mark L. Baum 26:06 What does the rebranding of the company mean? 27:00 Pharmaceutical names: VEVYE 28:22 How will you market VEVYE in the US? 29:48 Fortisite 31:59 What is the future of the company? 32:47 What do you think of Dr. Wiley Chambers' retirement? 34:09 Intro of Jeannette Bankes 36:51 Describe your last five years in the ophthalmic space: the good, the bad, the ugly 39:16 ·       If you could change anything in the ophthalmic industry, what would it be? 42:53 ·       How excited are you about robotics? 44:06 ·       Tell us about your promotion 44:52 ·       How can we develop a more diverse leadership in ophthalmology? 45:31 Preview of episode 22 48:01 Feedback, questions and guest suggestions at eyeluminaries@healio.com 48:18   Jeannette Bankes is the president and general manager of global surgical franchises for Alcon. Mark L. Baum is the founder, chairman of the board and chief executive officer of Harrow. Eric D. Donnenfeld, MD, is a cornea, laser cataract and refractive surgeon for OCLI Vision. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Calvin C. Roberts, MD, is a program manager for health science futures at ARPA-H. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Bankes is the president and general manager of global surgical franchises for Alcon. Baum is the founder, chairman of the board and chief executive officer of Harrow. Donnenfeld reports consulting widely across the ophthalmic industry with relevant disclosures in this episode as a consultant with Alcon, Bausch + Lomb, LensGen, Ocular Therapeutix and Omeros. Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Thompson is the director of refractive surgery at Vance Thompson Vision. Roberts is program manager for health science futures at ARPA-H.

Most of us want to see God do more in the world around us but we don't understand that God needs to first work in us and that will affect others. Kenny Luck is a pastor at Crossline Church in Laguna Hills, California. He is the author of 24 books covering marriage, family, and men's issues. He is the leader of Every Man Global LIVESTREAM and podcasts. He is currently on the Dangerous Good Tour in cities across the country empowering men to be dangerous with goodness and equipping them to have a positive impact on their families and communities. He shares how we can live from the overflow and set the Holy Spirit loose in the world around us. Check out Kenny's book “Overflow” Pick up Matt's book "Truth Plus Love" For more from Matt Brown, and to receive our free gift "5 Keys to Find Fulfillment in God" go to: Thinke.org

Caring for people and their experience, both as employees and as customers, is at the heart of a successful coffee shop. In order to consistently pursue that, an operator needs to have a strong grounding of personal values that directs their decisions and helps them weather the storms of entrepreneurship. Today we are talking with someone whose mission to facilitate community, caring, and connection through coffee has been a driving force behind the success of his company.  Nick Kassouf is the founder and owner of Tru Bru Organic Coffee and Humbowl Juice bar. With la roastery and locations in Orange, CA and Laguna Hills, CA, plus Henderson, NV, Nick and his team are keeping busy providing nourishing and meaningful spaces for their guests to slow done and enjoy coffee and good company.  In the years of operating and growing the coffee business and starting the juice bar, Nick has had to grow just as much personally. Today we will be exploring the story of Tru Bru and how this family run business runs and the why behind the operations that has led to their success.  I love the focus Nick has on creating a business that delivers more than just a product but reinforces a way of life that I think we all could benefit from adopting.  We discuss: Family History and Origins of True Brew Creating a people-first culture and focusing on hospitality  Hiring and Behavioral-Based Interviewing Choosing the right people who embody the mission and values of the business  Being willing to lead from the front and develop oneself in all aspects of the business  Addressing toxicity and cultural challenges early on to prevent negative impacts on the business and team. Taking action and not succumbing to complacency as the key to maintaining a healthy culture and driving business growth.  Why creating a caring and vibrant culture is crucial for fostering human connection in a coffee shop. Genuineness and a genuine care towards others Links: https://trubrucoffee.com/ IG: @TRUBRUCOFFEE Related episodes: Founder Friday! Youth, Foster Care, and Human Connections Through Coffee | w/ Miah Sommer of Astute Coffee in Omaha, NE

Yesterday I was the keynote speaker at the Southern California Area Republican Women's luncheon in Laguna Hills, CA. They asked me to speak about artificial intelligence and whether this new technology is a threat to our Constitutional Rights. Hint: Yes, it is. If you are in Southern California and are a woman (biological women only, please), I highly encourage you to join the Southern California Area Republican Women's (SCARW). For more information go to https://scarw.org. Subscribe to The Jeff Dornik Show on Rumble, Spotify and Apple Podcasts. The Evangelical Church was the last stand against the tyranny we face today… and the enemy knows this, which is why they infiltrated and hijacked the movement, rendering it largely useless. In the book Church & State authors like Pastor Greg Locke, Dr Michael Brown, Denise McAllister and Jeff Dornik break down exactly how the Left was able to use the Church to conquer America. Order your copy today! https://jeffdornik.com/store Are you looking for a natural and holistic approach to protect yourself from COVID-19, without relying on Big Pharma? Consider Z-Stack, a carefully curated combination of supplements known for their immune-boosting properties. Z-Stack offers a science-backed alternative to traditional pharmaceutical solutions, harnessing the power of vitamins C, D3, zinc, and quercetin to strengthen your immune system. By choosing Z-Stack, you can take control of your health while minimizing your dependence on Big Pharma. Protect yourself the natural way with Z-Stack and prioritize your well-being. Use discount code JEFF5 when you order at https://jeffdornik.com/zstack. Sign up for pickax, the social media platform that protects free speech, is not beholden to Big Tech, has algorithms that amplify your voice and provides monetization opportunities for content creators. https://pickax.com Subscribe to The Jeff Dornik Show on Substack to get all of Jeff's shows, interviews and articles directly to your email inbox. Become a paid subscribe to get access to his weekly exclusive show for paid subscribers only. Subscribe at https://jeffdornik.substack.com.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Vance Thompson, MD, Adrienne Graves, PhD, Sean Ianchulev, MD, and Kristen Harmon Igenito, live from AAO Eyecelerator. Welcome to the Eyeluminaries podcast :01 Review of episode 19 1:31 Intro of Vance Thompson, MD 2:13 What is the secret to your success? 3:54 How many fellows have you trained? 5:20 How has having a fellowship training program at Vance Thompson Vision impacted your practice? 6:23 What are the two recently approved products that you are amazed by? 10:02 What is your favorite wine? 12:55 What is your favorite dad joke? 15:25 Intro of Adrienne Graves, PhD 16:59 How does your background help you serve in the companies and non-profits you work with? 19:43 What do strategics do for companies? 24:13 Prescription drug names 25:53 Intro of Sean Ianchulev, MD, MPH 29:45 How do your ideas evolve? 31:53 ·       Who or what inspires you? 45:58 Intro of Kristen Harmon Ingenito 49:39 How is the software different? 51:45 How is market research changing? 55:19 What are you most optimistic about in terms of trends? The most challenging? 57:18 At what point in your life did you decide to work in market research? 59:05 Preview of episode 21 1:02:32 Feedback, questions and guest suggestions at eyeluminaries@healio.com 1:02:40   Adrienne Graves, PhD, serves as an independent director on the boards of Iveric Bio, Nicox S.A., Greenbrook TMS NeuroHealth, Surface Ophthalmics, Qlaris Bio, and TherOptix and serves as director on the Foundation Boards of the American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation (Emeritus), Retina Global, Himalayan Cataract Project, and the Foundation Fighting Blindness Retinal Degeneration Fund. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Sean Ianchulev, MD, MPH, is a Harvard-trained physician-scientist, a professor of ophthalmology and the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health. Kristen Harmon Ingenito has more than a decade of experience in the ophthalmic industry, with nine of those years analyzing data and reporting for Market Scope. Kristen's industry experience began in 2005 at Market Scope, where she served in many roles, including editing, analysis, sales, and marketing. She then joined an ophthalmic patient education software company, where she worked closely with physicians to help drive value in all aspects of their practices, while also training incoming executives on the business of eye care. She returned to Market Scope with added experience to help expand the company's portfolio of products and services. Source: Market Scope Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Vance Thompson, MD, is a board-certified ophthalmologist who specializes in refractive surgery including laser vision correction, implant vision correction and advanced cataract surgery and is the director of refractive surgery at Vance Thompson Vision. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Graves serves as an independent director on the boards of Iveric Bio, Nicox S.A., Greenbrook TMS NeuroHealth, Surface Ophthalmics, Qlaris Bio, and TherOptix and serves as director on the Foundation Boards of the American Society of Cataract and Refractive Surgery (ASCRS) Foundation, Glaucoma Research Foundation, American Academy of Ophthalmology Foundation (Emeritus), Retina Global, Himalayan Cataract Project, and the Foundation Fighting Blindness Retinal Degeneration Fund. Hovanesian consults widely in the ophthalmic field. Ianchulev is the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health. Ingenito develops products and provides services to Market Scope. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Thompson is the director of refractive surgery at Vance Thompson Vision.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Peter Slack, Greg Kunst, Rich Small and Uday Devgan, MD, FACS, FRCS, live from OSN New York. Welcome to the Eyeluminaries podcast :01 Review of episode 18 :18 Intro of Peter Slack 1:47 How did OSN start? 2:35 When did you get into meetings and where do you see meetings going? 5:40 Where do you see media going? 7:46 How did you end up running the Hawaiian Eye Meeting? 10:53 Intro of Greg Kunst 13:59s What will be the biggest challenges introducing a new paradigm for a traditionally surgical disease? 14:52 What can you tell us about Aurion's plans for cell therapy in other front and back of the eye disease, in addition to endothelial cell disease? 17:04 What should I be telling my patients who have future need for endothelial keratoplasty? 19:17 What is the status of Aurion in Japan? Is the competition on the horizon? 22:13 Intro of Rich Small 25:53 Why are you excited about the Encapsulated Cell Therapy Platform? 27:12 Why MacTel? 31:52 What is the status of the Neurotech BLA? 32:26 ·       Give us a good Jim Mazzo story 34:38 Intro of Uday Devgan, MD, FACS, FRCS(Glasg) 37:05 Tell us about how you got started producing one video per day 38:10 Tell us a story about a doctor from far away who is influenced by your teaching 40:38 If you could change one thing in residency training today, what would it be? 41:59 Preview of episode 20 43:51 Feedback, questions and guest suggestions at eyeluminaries@healio.com 44:04   Uday Devgan, MD, FACS, FRCS(Glasg), is Healio|OSN section editor for Ocular Surgery News. He is in private practice, specializing in cataract and refractive surgery, at Devgan Eye Surgery in Los Angeles and a full partner at Specialty Surgical Center in Beverly Hills, California. He has previously served as full clinical Professor of Ophthalmology at the Jules Stein Eye Institute at the UCLA School of Medicine as well as Chief of Ophthalmology at Olive View-UCLA Medical Center and has been actively involved in resident surgical teaching for over two decades. He owns and operates CataractCoach.com. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Greg Kunst is president, chief executive officer and board member at Aurion Biotech. He is focused in areas such as R&D, clinical development, corporate development, strategy, marketing, commercial, business development, market access and medical affairs with extensive knowledge of global health care markets (North America, Latin America, Europe, Asia), global commercialization and market development, upstream and downstream marketing, market access, and medical affairs for medical device, drug delivery systems, diagnostic systems, biotechnology, cell therapies, gene therapies, biologics, and pharmaceutical products. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Peter N. Slack is president and chief executive officer of The Wyanoke Group. Peter is past-Chairman and a current member of the Board of Trustees for the Center for Family Services, a nonprofit human services agency. Other professional titles and memberships have included Board of Directors of the International Association of Association Management Companies and Board of Directors of the American Medical Publishers Association. In addition, Peter is President of the Broadway Theatre of Pitman in Pitman, NJ.  Disclosure: The Wyanoke Group is the holding company for Healio, the producer of the Eyeluminaries podcast. Rich Small is chief executive officer and member of the board of directors for Neurotech. He originally joined Neurotech in July 2007 as the company's chief financial officer. He has in excess of 30 years of both private and public life sciences experience and more than 40 years of overall financial and operational management. Previously Rich served as Senior Vice President and Chief Financial Officer of Point Therapeutics, a publicly traded biotechnology company focused in developing treatments for various cancers. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Devgan owns and operates CataractCoach.com. Hovanesian consults widely in the ophthalmic field. Kunst is president, chief executive officer and board member at Aurion Biotech. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Slack is president and chief executive officer of The Wyanoke Group. Small is chief executive officer and member of the board of directors for Neurotech. The Wyanoke Group is the holding company for Healio, the producer of the Eyeluminaries podcast.

039 - September 30, 2023Rich DeMuro talks tech news, tips, gadget reviews and conducts interviews in this weekly show. Airs 11 AM - 2 PM PT on KFI AM 640 and syndicated on stations nationwide through Premiere Networks. Stream live on the iHeartRadio App or subscribe to the podcast.Follow Rich on X, Instagram, Facebook and Threads.Call 1-888-RICH-101 (1-888-742-4101) to join in!RichOnTech.tvRich On Tech Show WikiRich recapped his top-secret trip to NYC. He has been comparing the iPhone 15 Pro Max photos to the iPhone 14 Pro, the Nothing (2) phone and the Pixel 7 Pro.In NYC he saw a luggage robot, a neat RFID self-checkout at UNIQLO and a self-checkout at the airport that asked him for a tip!Fernando in Laguna Hills wants a new SD Card reader that has a battery and Wi-Fi so he can access files on the go. Rich says to check out the NewQ Filehub which seems to fit the bill but hasn't tested it.The CEO of X apparently doesn't have the X app on her iPhone homescreen.Michael in Canoga Park wants the Opera Browser on Kindle Fire tablet. Rich says you need to find the APK and then sideload it, but first you need to allow outside apps, so be aware of the security implications of doing this.Google is rolling out a redesigned At a Glance widget.Google is rolling out a new AI powered Memories tab in Google Photos.Jack in Goldendale, Washington, wants to know if he can take the old SIM card out and pop it into the new phone.James writes in about how his daughter was scammed and shared her iPhone screen to scam artists and he's worried that he should change his Wi-Fi password.Paul in Brea wants to know if he can safely get rid of his old computers at a weekend recycling event. Ideally you should erase data from the computers using a factory reset or an app like shredOS, or use a screwdriver to remove the hard drive and drill through it or take it to a recycling center with a shredder.There's a new Fitbit Charge 6, which adds more accurate heart rate tracking, new workouts, GPS and more. It's $160 and available this fall.Bill in San Diego wants to know how to download all Gmail emails. Rich says to use Google Takeout. Also, it's a good idea to set up a Legacy Contact on Google and Apple that can download your data in the event of your death.Matthew Cassinelli, discusses iPhone Shortcuts and how to best use the iPhone 15 Pro's new Action Button. He mentioned the Soro app for controlling Sonos.Karen is in San Pedro wants to know if she needs a new phone because it won't charge.ChatGPT gets voice and image capabilities.Google is ending it's support for Basic HTML.Antonio in Covina asks if he should leave his laptop plugged in all the time.Windows brings back the “never combine” action for the taskbar.Meta has new AI features coming to apps including WhatsApp, Messenger and Instagram and Facebook Stories. They are AI stickers, Restyle and Backdrop.David Henry, President and General Manager of Connected Home Products and Services at NETGEAR to talk Wi-Fi. His recommended Orbi for mesh networking and Nighthawk for a standard router.Teens have a complicated relationship with their smartphones; they're bombarded with notifications and spend a majority of their time on social media, including TikTok.MrBeast is the top digital creator, making $82 million a year.Nathan sends in a reminder that if you're Samsung phone isn't getting the latest updates you can force it using the desktop Smart Switch app.Donna warns about a tech support scam that almost got her senior citizen friend.Scott says he is having issues with eSims from Airalo, but likes the customer service they provide.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Julia Haller, MD, about the latest developments in retina, residency training and more. Welcome to the Eyeluminaries podcast :01 Review of episode 17, live from Octane OTF :41 Bausch + Lomb makes a number of big moves under the new Brent Saunders regime 1:40 Mark Baum and Harrow Health have also been making a number of acquisitions 3:59 FDA approves Xdemvy for Demodex blepharitis treatment 5:45 Former CEO of Johnson & Johnson Alex Gorsky elected lead director of Neurotech's board 7:47 John begins new clinical committee for ASCRS, digital 9:32 Julia Haller, MD introduction 11:30 ReST Committee update on intraocular inflammation reported in patients who received Syfovre at the American Society of Retina Specialists annual meeting 13:44 The FDA approved Izervay for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Astellas Pharma 14:16 Novartis is discontinuing the development of GT005 for the treatment of geographic atrophy secondary to dry age-related macular degeneration 14:36 How has the latest retina news affected patients and physicians? 14:53 The development of biosimilars 19:50 Discussion on pricing of products 21:57 The evolution and future of residency programs 23:34 Fun with retina drug names 27:15 Preview of episode 19 at OSN New York 29:46 Feedback, questions and guest suggestions at eyeluminaries@healio.com 30:15 Thanks for listening 30:27 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Julia Haller, MD, is Ophthalmologist-in-Chief and William Tasman, MD Endowed Chair at Wills Eye Hospital and Professor and Chair of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Haller reports being on the board of directors at Bristol Myers Squibb, Opthea and Outlook Therapeutics. She is consultant to Aura Biosciences, Bionic Sight, Lowy Medical Research Institute and Regeneron.

Last Sunday, Green Girl was invited to Laguna Hills to conduct an impromptu interview with legendary shoe designer, Steven Smith, also known as the “Godfather of Dad Shoes” (although you'll learn he's not that crazy about that title). Steven was in the area picking up a new car body and swung by The Hills Hotel to discuss all things YEEZY and design.While Ye has been seen running around Europe barefoot, Green Girl and Steven both showed up to the hotel wearing Wave Runners, one of Steven's popular YEEZY designs. They sat down together in an empty boardroom, which likely gave Steven flashbacks to his bleak corporate days at Nike, having to appease several bosses before any sketch was approved. Steven described Ye's leadership style as “exhilarating,” and explained why he prefers the collaborative, free-flowing creation process at YEEZY to the formulaic systems he was forced to follow while working in corporate America.Since joining the YEEZY team in 2016, Steven has worked closely with Ye on some of YEEZY's most iconic designs and credits Ye for pushing him beyond his own artistic limitations. A dangerous freethinker himself, Steven has ridden every wave with Ye the last couple years, no matter how rocky the waters have gotten. Together, they have disrupted modern sneaker culture by redefining the way shoes are engineered and delivered to the public.Two of Steven's friends, Will Holmes, “The Mayor of OC” and Jen Lebrity of the clothing brand “Boho Rocker Collection,” join them on the podcast to talk about Ye, fashion and their new reality show currently in production, “The New OC.” Green Girl's brother also makes an appearance, donning an ironic Punisher T-shirt, and asks Steven advice on how to crawl out of a dark hole after hitting rock bottom.During the interview, Steven points out an awkward chandelier propelled from the ceiling. In that moment, it becomes clear he can draw inspiration from just about anything in the modern world, finding joy in even a sparkly mismatched hotel decoration.This interview is hilarious, thought-provoking and insightful and gave Green Girl hope for the future of YEEZY.Follow our guests:Steven Smith: @stevensmithWill: @mayorofocJen: @bohorockercollection Andy: @andyhagen_Follow our host: KP: @kanyespostsSupport the Channel: linktr.ee/kanyesposts

Kenny Luck is the Leadership Pastor at Crossline Church in Laguna Hills, California. He was previously the Men's Pastor at Saddleback Church in Lake Forest, California from 1997-2014 and he's considered to be an expert in the field of men's issues.   Kenny is also the Founder and President of Every Man Ministries which helps churches worldwide to develop and grow healthy men's communities with the goal to end child abuse, father-less-ness and protect women and children.   He has authored and coauthored 21 books, including Every Man, God's Man; Every Young Man, God's Man; and the Every Man Bible Studies from the best-selling Every Man Series.   To contact Kenny, visit his website at http://www.EveryManMinistries.com    ---------------------------------   If you want to help us transform the lives of even MORE MEN for God's glory, please take a minute to leave us a helpful REVIEW on iTunes: http://www.rmcpodcast.com and SHARE this podcast with any young man (or men) you're mentoring or discipling.   And make sure you don't miss an interview episode by signing up for our Man-to-Man eNewsletter at http://www.RealMenConnect.com, and grab your FREE copy of the Real Men Victory Tracker.    Are you stuck? Want to go to the next level in your marriage, career, business, or ministry?  Then maybe it's time you got a coach. ALL CHAMPIONS have one. Let me coach you to help you strengthen your faith, improve your marriage, spiritually lead your family, achieve more, balance your time, grow your ministry, or even stop an addiction. Click here for details: http://www.RMCfree.com    Talk with Dr. Joe 1-on-1: Want to talk to the host? Time slots are limited, but Dr. Joe takes on a few Breakthrough Calls a week to personally help you with your personal life, work, and family challenges.  The call is FREE, but slots are limited to ONE call only.  NO RESCHEDULES.  Just click on the link below and select the BREAKTHROUGH CALL option to set up an appointment: https://TalkwithDrJoe.com   Also join us on: Join the Real Men 300: http://www.RealMen300.com Facebook Group: http://www.realmenuniversity.com/ YouTube: http://www.RealMenTraining.com Facebook: @realdrjoemartin Instagram: @realdrjoemartin Twitter: @professormartin

Rich talked about a tech support scam that takes over your computer. When in doubt, press Control + Alt + Delete at the same time on your keyboard, then select your web browser and hit End Task. You can also turn off your computer or restart it. Whatever you do, don't give access to your computer, or download any software.Jennifer in Laguna Hills wants to know what to do with old cell phones. Rich recommends checking out this list of places that take them as a donation. Rich also likes Gizmogo, Best Buy Mail in Recycling Boxes, EcoATM.Marta in Laguna Nigel wants to know if there's an Android app that lets you set audio reminders by voice and have it announce the reminder at a certain time. Rich recommended Talking Recordable Voice Alarm, Talking Alarm Clock Beyond and Voice Memo Reminder but all of them require some level of manual time setting for the alarm. Listeners recommend using Alexa for this functionality!Rich used Lugg to get his new furniture delivered and it mostly worked out great. He then sold his old couches on OfferUp and the process was excellent.Sharon in Williamsburg, Ohio wants to know how to improve her Wi-Fi signal. Rich recommends moving the router to a more central location in the room.David in Orange wants to know why his phone number is out there.Google is making it easier to remove search results about you that contain your personal information.Nick in Anaheim wants to know if his computer was hijacked by ransomware.Kimber Streams of Wirecutter shares top affordable laptop and Chromebook picks under $1000.Patricia is in Southern California wants to know why her Wi-Fi is still showing even though she cut the cable to her box and cancelled service.David in Cerritos wants to know how to find the phone number of an old friend. Rich recommends Sunshine Contacts, Google Contacts, Siri Search on iPhone and WhitePages.com to do a reverse search of someone's address or name to find their phone number.Here's how to set up vertical app drawer scrolling on a Samsung phone.Liz in Riverside wants to know how to get rid of old hard drives from her deceased husband's computers. Rich recommends an e-waste recycling facility that offers hard drive shredding, or an application called DBAN or similar. Listener Tom recommends freeware called CBL Data Shredder.Verizon now has a $25 unlimited plan through Visible.Scam alert: Watch out for bogus QR codes to pay for parking lots and meters.Nina in San Bernardino wants to know why she can't access her Outlook email through Chrome. An extension might be interfering, check them here.Ron asks if there is a free QR Code generator that will take an iPhone contact entry and turn it into a QR code that the recipient can scan and add to their contacts? Rich likes HiHello. See his card here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Greg Munck is a combat-promoted Marine who served his country with honor during the Gulf War. He is also the accomplished author of the book, The Guide — Survival, Warfighting, Peacemaking. After completing his service in the military, Greg continued his career in the private sector as the Asia Pacific Regional Manager for Q-Logic Corporation.After a call to pursue full-time ministry, he is now the lead pastor and co-founder of Crossline Church in Laguna Hills, California. Greg is a passionate advocate for military and veteran personnel worldwide and frequently travels to speak for The Guide Soldier Foundation, an organization dedicated to supporting active and veteran service members. Greg has been happily married to his wife, Kymbry, since 1992, and together they are proud parents of five children, some of whom have made appearances on television and in film.www.gregorymunck.net 

Happy 100 Episodes!! Thank you so much for being here! Join me on this very special episode with someone who had a HUGE impact on my HSP journey, Dr. Ray Gin. Dr. Ray Gin is a graduate of the Southern California University of Health Sciences. He is a Certified Functional Medicine Practitioner and has been in private practice for 22 years. He maintains a practice in Laguna Hills, CA. He is a published author, media personality, and lectures nationwide. Previously, he was a radio host for a prime time talk radio show on health. Gin discovered the connection between food intolerances/sensitivities and significant emotional traumas over 14 years ago and has helped many people regain their ability to enjoy foods and previously triggering environmental things again. His search for methods to help bring this liberating process to more people who suffer has brought him to develop the groundbreaking Emotional Allergy Technique™. Learn more about Dr. Gin's New Course Visit Dr. Gin's Website

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at OCTANe OTS with Mark Leahey, Brent Saunders, Yari Mitchell and Robert Dempsey, discussing their experiences and influence across the ophthalmic space. ·       Welcome to the Eyeluminaries podcast :01 ·       Review of episode 16 with Stephen McLeod, MD :28 ·       Preview of episode 17, live at Octane OTS 1:00 ·       Introduce Mark Leahey, president & CEO for the Medical Device Manufacturers Association 1:23 ·       Challenges in medical device 2:19 ·       Is it possible for the government to reduce regulation of medical devices while still protecting patients? 4:32 ·       What is MDMA doing for sustainability? 6:50 ·       What is one issue that device manufacturers need to implement? 9:04 ·       Introduce Brent Saunders, Chairman and CEO of Bausch + Lomb 12:23 ·       What's different about Bausch + Lomb today that wasn't around when you first worked for the company? 13:27 ·       Tell us about other products at Bausch + Lomb. 19:22 ·       Introducing Yari Mitchell, the president of Y Factor Consulting, Inc. 23:31 ·       What have been the most important changes in the ophthalmic industry over the past couple of years? 24:58 ·       What advice would you give to an early-career person? 26:15 ·       Favorite memories of Jim Mazzo 29:14 ·       Introducing Robert Dempsey, CEO and President of AsclepiX Therapeutics 32:10 ·       What was it like to leap from medical sciences to a leadership position? 33:22 ·       Managing a pipeline that includes both retinal and cornea treatments 35:05 ·       How do you establish yourself as a competitor in age-related macular degeneration research in a mature and crowded market with limited resources? 36:10 ·       Creating a retinal treatment delivered via the suprachoroidal route 37:28 ·       The Holland Foundation For Sight Restoration seeking to spread access to eye care for patients and the importance of giving back 38:27 ·       Feedback, questions and guest suggestions at eyeluminaries@healio.com 44:00 ·       Thanks for listening 44:19 Robert Dempsey is the CEO and president of AsclepiX Therapeutics. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO of the Medical Device Manufacturers Association. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Yari Mitchell is the president of Y Factor Consulting, Inc. Brent Saunders is the chairman and CEO of Bausch + Lomb. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Dempsey is the president and CEO of AsclepiX Therapeutics. Hovanesian consults widely in the ophthalmic field. Leahey is the president & CEO for the Medical Device Manufacturers Association. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Mitchell is the chief business development officer at AcuFocus and the president of Y Factor Consulting, Inc. Saunders is the chairman and CEO of Bausch + Lomb.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Stephen McLeod, MD, about his new position and the future of the American Academy of Ophthalmology. ·       Welcome to the Eyeluminaries podcast :01 ·       Review of episode 15, live from Eyecelerator :37 ·       Preview of episode 17, live at Octane OTF 1:07s ·       Théa to acquire seven branded ophthalmic products from Akorn 2:17 ·       FDA approves Miebo to treat signs, symptoms of dry eye disease 5:11 ·       OCS-01 eye drops meet primary, secondary endpoints in diabetic macular edema phase 3 trial 8:56 ·       ‘One of my greatest honors': Jim Mazzo awarded Ellis Island Medal of Honor 10:38 ·       Introduction Stephen McLeod, MD 12:14 ·       What's been your biggest challenge transitioning from clinical practice to your current position? 14:16 ·       Where is the AAO going now? 17:50 ·       Prior authorizations are the bane of operational existence. What is AAOs role in reforming this system? 22:59 ·       The future of meetings 30:27 ·       Preview of episode 17 35:44 ·       Feedback, questions and guest suggestions at eyeluminaries@healio.com 36:47 ·       Thanks for listening 54:02 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Stephen McLeod, MD, is the CEO of the American Academy of Ophthalmology. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. McLeod is the CEO of the American Academy of Ophthalmology.

Greg Munck is a combat-promoted Marine who served his country in the Gulf War. Greg is the author of the book The Guide: Survival, Warfighting, Peacemaking just released on May 9th, 2023. He is currently the lead pastor and co-founder of Crossline Community Church in Laguna Hills, California, and travels speaking for The Guide Soldier Foundation and SOF Missions, which serves active and veteran military personnel worldwide. He has been married to his wife, Kymbry, since 1992, and together they have five children who you may have seen in TV and film. www.gregmunck.net www.ordertheguide.com Tired of Drinking? Try Our 30 Day Quit Drinking Dude Challenge!  Follow us on Instagram @ThatSoberGuyPodcast Grab a CLEAN Cause! Go to www.cleancause.com and get 20% off your order with promo code SOBERGUY Jumpstart Your Life Without Alcohol in 10 Days! Join Us in That Sober Guy Men's Locals Group and connect with over 500 men living free from alcohol at  https://www.thatsoberguy.com/mens-group For More Resources go to http://www.ThatSoberGuy.com Invite Shane to Speak - https://www.thatsoberguy.com/speaking Contact Us: https://www.thatsoberguy.com/contactus Music - Going Late courtesy of Humans & Haven Sounds Inc. Need a Meeting? https://www.thatsoberguy.com/meetings National Suicide Prevention Lifeline - 1-800-273-TALK (8255)  

Follow Rich on Instagram!Rich talks about his visit to Austin for iHeartCountry Fest, including hitting up a BBQ place, live music and discusses how his hotel room has a record player in it. Now he wants this Victrola Stream Onyx turntable that works with Sonos.Rich discusses Google I/O and talks about their AI plans, plus new features coming soon to Maps, Gmail and Google Photos.Myriam Joire joined Rich to talk about Google I/O hardware including the Pixel 7a, Pixel Fold.Tom emailed asking for a tool that can help overhaul his resume. Rich recommended checking out Leet Resumes.Watch out for this fake Chrome Update Error scam that could infect your computer with malware.Rich mentioned that he watched the Apple TV+ movie Ghosted and thoroughly enjoyed it but found it ironic that they used a Tile instead of an AirTag.Pat in Laguna Hills asks for a new chromebook, do you like EMMC or SSD. Emmc is slower but cheaper, SSD is faster but more expensive. There are also size limitations.Peloton is recalling 2.2 million bikes because of issues with the seat. Contact them for a free repair kit.Rich mentioned that he got a new tracking device called Eufy SmartTrack Card which is a credit card style AirTag.Ron in Arizona asks about setting up a wifi network in a large church. Rich recommends using a prosumer device like Ubiquity.Cherylynn Low from Engadget describes her experience with Google's holographic video chat called Project Starline.Twitter has a new CEO.Sam in Hemet asks if he can transfer Google Play games from one phone to another and save his current progress. Rich in Illinois asks about using his collection of MP3's on his phone. Rich suggested transferring some of the files over or using YouTube Music's Upload feature.Apple brings Final Cut Pro and Logic Pro to iPad.New rankings from AV Test for Top Antivirus software.Eric Switzer of TheGamer.com joined to discuss the new Zelda game and Peridot, the new game from the makers of Pokemon Go. If you sign up for Peridot, use Rich's referral code UIZQFPU4KLyft is discontinuing shared Pool rides. Rich discusses his experience with Alto, a premium car service.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at the Eyecelerator 2023 with five special guests to discuss the future and developments in eye care. ·       Welcome to the Eyeluminaries podcast :00 ·       Preview of episode 15 :32 ·       Review of episode 14, STAAR Surgical :40 ·       Nick Curtis, CEO of Lensar 1:41 ·       Lensar is a unique company with loyal customers. How have you achieved that? 3:21 ·       What are the positives and challenges to not having a large organization as support? 4:09 ·       Where do you see the company and its products evolving over the next 5 years? 8:01 ·       Do you think the company is going to grow because you are taking share? Or because you are taking share and the market is going to grow? 10:06 ·       What is the accelerator for market growth? 10:19 ·       Who's your favorite Chicago team? 12:03 ·       Juliet Bakker, managing director and founder of Longitude Capital 13:11 ·       What makes ophthalmology an appealing specialty to you from an investment and a personal perspective? 14:30 ·       Give a sense of how you see Eyecelerator as an investor. 18:32 ·       What did you learn from failed investments? 21:39 ·       What are the signs of success that you look for? 23:03 ·       Ramin Valian, vice president Eye Care Allergan/AbbVie 24:31 ·       What is happening in ophthalmology at AbbVie? 25:21 ·       What were the key learnings after launching Vuity? 27:52 ·       Does ophthalmology have the same momentum as aesthetics? 30:12 ·       Susan Siw Daniels, PhD, chief scientific officer at Avellino Labs 34:11 ·       Why is your background perfect for Avellino? 35:06 ·       What things did you see transform in other specialties that you see potentially happening in ophthalmology? 38:02 ·       What data are you looking for to expand predictive testing and treatments in eye care in the future? 39:07 ·       How do you get ophthalmologists more involved in genetic testing? 40:30 ·       Julie Schallhorn, MD, MS 43:00 ·       What's new at the Eyecelerator? 44:42 ·       What are the signs of success in a startup company? 47:44 ·       What is your advice for people who want to balance their time with a medical career and personal life? 49:45 ·       Preview of episode 16 53:28 ·       Feedback, questions and guest suggestions at eyeluminaries@healio.com 53:56 ·       Thanks for listening 54:02 Juliet Bakker is a managing director and founder of Longitude Capital. Nick Curtis is chief executive officer and member of the board of directors at Lensar. Susan Siw Daniels, PhD, is the chief scientific officer at Avellino. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Julie Schallhorn, MD, MS, is an assistant professor of ophthalmology at UCSF. Ramin Valian is the vice president of Eye Care Allergan/AbbVie. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Bakker serves on the boards of Ceribell, Engogenex, Nalu Medical and RxSight. Curtis is a member of the board of directors for Lensar. Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Schallhorn sits on the Ophthalmic Technology Assessment Committee for Refractive Surgery for the American Academy of Ophthalmolgy and the Young Eye Surgeons Committee for the American Society of Cataract and Refractive Surgeons.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the new leadership at STAAR Surgical with Tom Frinzi, president and CEO; Warren Foust, COO; and Magda Michna, PhD. •    Welcome to the Eyeluminaries podcast :00 •    Review of episode 13 with Gil Kliman, MD :23 •    Review of episode 12, the Annual Drug Name Awards :52 •    Preview of episode 14 1:20 •    Tom Frinzi, president and CEO; Warren Foust, COO; and Magda Michna, PhD, introduction 1:28 •    Tom: What were the qualities and factors that made you choose Foust and Michna to join the STAAR Surgical team? 3:42 •    Magda: Why STAAR Surgical? 6:07 •    Magda: What can you do to help repair the relationship between STAAR Surgical and the FDA? And what do you hope to change at STAAR? 8:07 •    Warren and Magda: What's the 100-day plan? 9:47  •    Tom: How does STAAR Surgical plan to make the ICL exciting for doctors and patients in the US? 13:17 •    Warren: How do you get physicians excited about the ICL? 16:26 •    Tom and Warren: How do you compete with other companies that have an advantage when it comes to selling STAAR's technology? 18:20 •    What kind of impact would you like to have on STAAR Surgical 3 to 5 years from now? 23:14 •    STAAR Surgical and the Jonas Brothers 28:25 •    Wrap up and thank you, Tom, Warren and Magda 29:51 •    Preview of episode 15 30:04 •    Feedback, questions and guest suggestions at eyeluminaries@healio.com 31:00 •    Thanks for listening 31:36 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Warren Foust is the chief operating officer at STAAR Surgical. Thomas Frinzi is the president and chief executive officer at STAAR Surgical. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Magda Michna, PhD, is the chief clinical, regulatory and medical affairs officer at STAAR Surgical. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Foust is the chief operating officer at STAAR Surgical. Frinzi is the president and chief executive officer at STAAR Surgical.

Joan Bernard Bradley, from Laguna Hills, California, USA

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the Silicon Valley Bank collapse and its impact on investing and innovation in the field of ophthalmology with Gilbert H. Kliman, MD. ·       Welcome to the Eyeluminaries podcast :01 ·       Review of episode 12 with Richard L. Lindstrom, MD :30 ·       Preview of episode 13 1:35 ·       Gil Kliman, MD, introduction 2:36 ·       History of Silicon Valley Bank 4:25 ·       Silicon Valley Bank's collapse 6:08 ·       Guest welcome 8:07 ·       Was the collapse a surprise? 8:22 ·       Kliman on major themes of this event being how fast it happened and how unprecedented it was for companies 9:34 ·       How many ophthalmic companies have been affected, and what are the next steps for these companies? 10:16 ·       Kliman on the turning point when the FDIC stepped in on Sunday 11:50 ·       Have you had companies report that they have accessed their funds at Silicon Valley Bank? 12:27 ·       Kliman on his experience with Silicon Valley Bank 12:45 ·       What should companies do going forward, and what are you advising companies? 14:17 ·       Kliman on figuring out a new strategy and the unique issue of 90% of depositors being above the $250,000 FDIC threshold 16:13 ·       What is the survival rate for small banks now? 17:31 ·       What do you think the flavor of the room will be at Eyecelerator@ASCRS? 19:20 ·       Kliman's advice for companies to focus on burn rates 20:35 ·       The physician's perspective for supporting innovation and small business 21:54 ·       How strategics can continue to partner with startups using their venture arm 24:04 ·       Information on the Eyecelerator meeting 25:46 ·       Wrap up and thank you, Gil 26:16 ·       Feedback, questions and guest suggestions at eyeluminaries@healio.com 26:45 ·       Thanks for listening, and preview of episode 14 27:11 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Gil Kliman, MD, is managing partner at InterWest Partners and is co-founder and program director of Eyecelerator. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Kliman is managing partner at InterWest Partners.

We kick off the new year from the first RFD event of the year in Laguna Hills where we're joined by Rebelle Rally driver and personal friend, Jessi Puffenbarger, who talks about the trials and tribulations of being a privateer. Then we bring you part 2 of episode 93 in the Cleaveland National Forest with longtime friends and occasional visitors of Rigged For Dirt, Matt Lorenger (3.2.1.adventure) and Eric Dalcin (American_Overland). We shoot the s#it and help you kill some time on the way to your next adventure (or work).

There's a relatively noticeable difference in treatment between a younger patient population and a geriatric one. How do you, as a practitioner, find ways to make your practice thrive with a patient base largely filled by patients 70 years and older? The guest on today's episode of Every Day Oral Surgery is Dr. Nguyen, who practices a full scope of oral and maxillofacial surgery with expertise ranging from wisdom tooth removal to a full range of dental implant and bone grafting services. He's a husband, father to five, and an avid surfer. Today we talk about how he ended up practicing in Laguna Hills, California, from marketing to networking with other local surgeons. We then dive into his patient base, which mostly consists of geriatric patients, and how this particular patient demographic differs from younger patients. He talks about the importance of educating patients and how he and his staff make sure that patients are clued-in on all the options available. He's passionate about taking care of his patients and providing the best possible care. Don't miss out on all this, and more, tune in now!Key Points From This Episode:A brief history of his training and an overview of his current practice setup.Points he has attributed to his success in a competitive environment.What it was like working with the other surgeons in his area and asking them for help. How he navigates marketing himself, as a surgeon, after moving to Laguna Hills. Types of procedures he does, or specializes in, as an oral surgeon in Laguna Hills.Doing implants with geriatric patients and how it differs from a younger patient.Whether age plays a factor in his decision making regarding immediate or staged implants.We touch on underlying medical issues and how they [may] affect treatment.We talk about the importance of educating patients.Dr. Nguyen shares some ideas about how to go about educating [elderly] patients. Why he thinks implants are the best invention ever.What appointments look like with geriatric patients.We end off with some rapid fire questions with Dr. Nguyen. Why keeping it simple pays off. Links Mentioned in Today's Episode:Laguna Hills Oral Surgery — https://www.lagunahillsoralsurgery.com/ The Mindset — https://www.amazon.com/Mindset-Psychology-Carol-S-Dweck/dp/0345472322 Dr. Quoc Nguyen Email — drnguyen@lagunahillsoralsurgeryLaguna Hills Oral Surgery Email — info@lagunahillsoralsurgery.com Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059KLS Martin PROMO CODE: EOSExo22 — https://www.klsmartin.com/ KLS Martin Headlights — https://www.klsmartin.com/en/products/headlights/ KLS Martin Headlight PROMO CODE: KLSPHL (Valid until mid January 2023)

In Season 4, Episode 10, we head to Sweden to explore Boda Borg... or at least that's where we thought were going with this episode. As it turns out, the President/ CEO of Boda Borg is an American business strategy visionary living in Laguna Hills, California named David Spigner. There is surprisingly little information about the Boda Borg story, and we are thrilled to share the tale of how he became the owner and President of what was originally a Swedish company. Boda Borg has been around since 1995. That is way longer than escape rooms have existed, and it was ingenious in the way it approached what they call "reality gaming." David Spigner recounts how he helped propel it from rooms decorated only with flat, 2D paintings into interactive multidimensional sets with movie-like narrative and feel. He candidly shares his global ambitions as well as the hurdles of trying to explain the appeal of Boda Borg to financial lending communities. David Spigner is an excellent storyteller, and we were enthralled with his tale of discovering and shaping Boda Borg. Spigner is an unusual guest in that his approach to the immersive gaming world comes from a very business-oriented, strategic mindset with aspirations towards massive global expansion. And yet, in chatting with him, it was clear that he intuitively understands the appeal of physically immersive gaming. This was a fascinating conversation that you shouldn't miss.   Show Notes   Episode Sponsors Thank you to our sponsors:  Morty - A free app for discovering, planning, tracking, and reviewing your escape rooms and other immersive social outings. Escape Tales - Escape Tales is an acclaimed series of tabletop escape room games— each featuring a unique blend of mind-bending puzzles masterfully woven into thought-provoking, robust narratives. Use code “roomescapeartist” for 25% off all Escape Tales products and Books of Rituals on Board & Dice. Buzzshot - ‘Customer Satisfaction Software' for your escape room business. Streamline your marketing and grow your escape room business with pre- and post-game features including robust waiver management, branded team photos, and integrated review management. Use code REPOD2022 in the dropdown list when booking a demo for 20% off your first three months. Reality Escape Convention - RECON Our escape room and immersive gaming convention, will be an incredible event for creators and consumers of the games we love. We hope to see you in Boston. Learn More about RECON. Music Credits  All music provided by GameChops:  "The Legend of LoFi" by Dj Cutman & James Landino "Hateno Village" by Mikel & GameChops Production Credits REPOD is produced by Lisa Spira and edited by Steve Ewing of Stand Inside Media.   

This episode's Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE---Episode Overview: During this episode, Bjarne Bergheim, President and CEO of Sonendo, a commercial-stage medical technology company committed to solving tooth decay, the most prevalent chronic disease globally, joins us to discuss his deeply rooted commitment and passion for his company's mission to save teeth and improve lives. While together, Bjarne shares his entrepreneurial journey, why and how he became Sonendo's first employee in 2007, and the bright vision for Sonendo's future. Join us as Bjarne, and I discuss the importance of oral care as we continue to work together to move the health of our world forward! Let's go!Episode Highlights:Bjarne's background and entrepreneurial journey What lead to the big vision for SonendoThe 3 building blocks of Sonendo A prediction of Sonendo and the Dentistry Industry in the future About our Guest: Bjarne Bergheim has served as Sonendo's President, Chief Executive Officer and a member of the board of directors since 2008. Mr. Bergheim was the company's first employee and previously served as Chief Operating Officer from 2006 to 2008. Prior to joining Sonendo, Mr. Bergheim was a co-founder and member of the management team of Fjord Ventures, LLC, a life science accelerator located in Laguna Hills, California focused on building and operating companies in the medical device, diagnostic and biopharmaceutical sectors.Previously, Mr. Bergheim was the first employee of 3F Therapeutics, Inc., which was acquired by ATS Medical and later by Medtronic, Inc. Mr. Bergheim received a B.S. in mechanical engineering from the University of California, Irvine and an M.S. in mechanical engineering from the California Institute of Technology. Mr. Bergheim also studied cardiovascular and biomedical engineering at NTNU, Norway in collaboration with Stanford University and California Institute of Technology.He has spent decades in the medical technology industry and is passionate about advancing Sonendo's mission to save teeth and improve lives.Links Supporting This Episode:Sonendo website: CLICK HEREBjarne Bergheim LinkedIn page: CLICK HERESonendo LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Today's episode is part 4 in Sandy's 7 part postpartum series. Her "birth squat team" as Wade likes to refer to them all played a huge role in getting her to feel herself again post birth, through all the physical recovery and the emotional journey too. Analise was Sandy's pelvic floor therapist who helped her TREMENDOUSLY - so much so we knew this needed to live forever on the Getting Magnetic platform!!This is something that could help everyone if we were all just educated on its benefits! Tune in and know if you are in the Orange County area you can book an appointment with her or her colleagues at PelvicSanity in Laguna Hills, California.Dr. Analise Richtsmeier - Pelvic Physical TherapistDr. Analise is passionate about helping women and men with pelvic health issues resolve their symptoms and get back to doing what they lovePrior to working at PelvicSanity, Dr. Analise founded an entire pelvic health program in Augusta, GA.  After returning to Southern California, Analise has worked in both in-clinic and in-home pelvic health, broadening her experience with patients.Analise has also been certified as a Pure Barre instructor and incorporates targeted exercise into her treatment techniques to help build a solid foundation for health.  An avid runner, when she's not in the clinic you can find Analise finishing marathons, spending time with her family or enjoying the Southern California sunshine.Timestamps: [5:01] What does "getting magnetic" mean to you? [5:30] How did you get into pelvic physical therapy? [8:11] How long have you been doing it? [11:56] What exactly is pelvic floor? [19:31] Men can benefit as well. [19:49] What is the process like of working with you? [23:11] How to work with Analise. Infinite BankingInterested in investing for you and your family's future with Infinite Banking? Email Wade at wcritides81@gmail.com or send him a message on instagram to take the next steps!To watch the webinar on youtube check it out here: https://youtu.be/qMtbFR_OuX8--Let's Connect!To get more info and updates on the podcast@gettingmagneticFollow our personal Instagram accounts@sandyclaus7@wellnesswithwadeCheck out our website for all things Getting Magnetichttps://www.sandyandwade.com/